Alphatec Holdings (ATEC) has drawn investor attention after a mixed run, with the stock down about 8% over the past month and roughly 38% in the past 3 months.
See our latest analysis for Alphatec Holdings.
The recent 1 day share price return of a 1.76% decline and 7 day gain of 0.41% sit against a much weaker backdrop, with the 90 day share price return of a 37.7% decline and year to date share price return of a 40.85% decline contrasting with a 1 year total shareholder return of 32.19%. This suggests earlier optimism has faded and investors are reassessing both growth potential and risk.
If this kind of volatility has you looking beyond a single name, it could be a time to scan the market for other healthcare names using our screener of 33 healthcare AI stocks as potential ideas.
With Alphatec shares well below recent highs and the stock trading at a substantial discount to some analyst targets, the key question now is whether the current price reflects undervaluation or if the market is already pricing in future growth.
Alphatec Holdings last closed at $12.28, while the most followed valuation narrative points to a fair value of about $24.62 per share, implying a large gap between price and that estimate.
Operational discipline, expense control, and infrastructure scalability have inflected the company into sustained profitability and free cash flow generation, directly improving net income and strengthening the balance sheet for future growth investment.
Want to see what sits behind that confidence in profitability and cash flow? The narrative leans heavily on revenue momentum, rising margins, and a future earnings profile that assumes a richer valuation multiple than today. Curious how those moving parts combine into a single fair value number? The full story is in the detailed assumptions.
Result: Fair Value of $24.62 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this upbeat view could be challenged if spine procedures shift toward less hardware intensive options, or if larger rivals pressure Alphatec's pricing and margins.
Find out about the key risks to this Alphatec Holdings narrative.
If this mixed sentiment has you undecided, it may help to review the underlying data yourself and determine your position promptly. To understand what optimism the market may already be pricing in, take a closer look at the 4 key rewards.
If you are weighing what to do next after reviewing Alphatec, this is a great moment to widen your net with a few focused stock shortlists.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English